Half of breast cancer patients stop taking key medications ahead of schedule, a decision that can increase their risk of relapse and death, a new study shows.The finding underscores the importance of working with patients to reduce side effects, especially at a time when patients are increasingly responsible for their own care, says Jennifer Obel, an American Society of Clinical Oncology breast ...